Blockage of spinal endothelin A receptors attenuates bone cancer pain via regulation of the Akt/ERK signaling pathway in mice
Bone cancer pain (BCP) is a common source of pain in patients with advanced stage and metastatic cancer; however, existing treatment for this kind of pain remains deficient. Being closely related to sensory change and inflammatory pain in both the central and peripheral nervous systems, endothelin A receptor (ETAR) plays an essential role in pain processing. As a result, ETAR antagonist has been reported to alleviate both neuropathic and inflammatory pain. Thus far, the role of ETAR in the process of BCP is still ambiguous.
Source: Neuropeptides - Category: Neuroscience Authors: Ming-Ming Han, Cheng-Wei Yang, Chi-Wai Cheung, Juan Li Source Type: research
More News: Back Pain | Bone Cancers | Brain | Cancer | Cancer & Oncology | Neurology | Neuroscience | Pain